FOXO1 or not FOXO1: that is the question

Authors

Marianne Mangeney (ORCID: https://orcid.org/0000-0002-9102-191X)
Maude Marchais (ORCID: https://orcid.org/0000-0002-5017-5509)

Institutions

Centre National de la Recherche Scientifique (FR)
Université Paris-Saclay (FR)
Institut Gustave Roussy (FR)
Canadian Nautical Research Society (CA)
Endress+Hauser (Switzerland) (CH)

Publication Details

Journal: Cancer Communications
Published: 2024-11-07
DOI: https://doi.org/10.1002/cac2.12624
Primary Topic: CAR-T cell therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Bristol-Myers Squibb
Ligue Contre le Cancer

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

FOXO1 or not FOXO1: that is the question

Marianne Mangeney, Maude Marchais

Nov 7, 2024

Cancer Communications

CAR-T cell therapy research

article

FOXO1 or not FOXO1: that is the question

Marianne Mangeney, Maude Marchais

November 7, 2024article en

Abstract

No abstract available for this paper.

Cancer CommunicationsVol. 45(1)

Centre National de la Recherche Scientifique (FR), Université Paris-Saclay (FR), Institut Gustave Roussy (FR), Canadian Nautical Research Society (CA), Endress+Hauser (Switzerland) (CH)

Bristol-Myers Squibb, Ligue Contre le Cancer

Good health and well-being

Openalex Percentile: Top 64%

CAR-T cell therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.